Inventor profile of:

Andrew Bogdan

City:

Evanston, Illinois

Country:

United States

Published Applications:

46

Last publication date:

2025-05-08

Top Assignees for applications by Andrew Bogdan

The entities that hold a legal rights for patent applications filed by inventor Bogdan Andrew:

Recent patent applications by Bogdan Andrew

Andrew Bogdan from Evanston, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-05-08
US20250145587A1
Chemistry; metallurgy

BROMODOMAIN INHIBITORS

#2 | 2025-04-17
US20250122160A1
Chemistry; metallurgy

PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF

#3 | 2025-02-06
US20250042894A1
Chemistry; metallurgy

PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF

#4 | 2025-01-16
US20250019374A1
Chemistry; metallurgy

PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF

#5 | 2024-05-16
US20240158368A1
Chemistry; metallurgy

Pyrrolidine Main Protease Inhibitors as Antiviral Agents

#6 | 2024-02-08
US20240043386A1
Chemistry; metallurgy

Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use

#7 | 2023-03-30
US20230101559A1
Chemistry; metallurgy

Bromodomain Inhibitors

#8 | 2023-01-19
US20230019236A1
Human necessities

PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF

#9 | 2022-07-07
US20220213041A1
Chemistry; metallurgy

Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use

#10 | 2021-08-19
US20210253551A1
Chemistry; metallurgy

Bromodomain Inhibitors

#11 | 2021-08-05
US20210238159A1
Chemistry; metallurgy

Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use

#12 | 2021-03-11
US20210070756A1
Chemistry; metallurgy

TETRACYCLIC BROMODOMAIN INHIBITORS

#13 | 2020-09-17
US20200291027A1
Chemistry; metallurgy

TETRACYCLIC BROMODOMAIN INHIBITORS

#14 | 2020-09-03
US20200277276A1
Chemistry; metallurgy

Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use

#15 | 2020-09-03
US20200277275A1
Chemistry; metallurgy

Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use

#16 | 2020-09-03
US20200277274A1
Chemistry; metallurgy

Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use

#17 | 2020-09-03
US20200277273A1
Chemistry; metallurgy

Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use

#18 | 2020-02-13
US20200048220A1
Chemistry; metallurgy

Bromodomain Inhibitors

#19 | 2019-12-26
US20190389861A1
Chemistry; metallurgy

TETRACYCLIC BROMODOMAIN INHIBITORS

#20 | 2019-10-17
US20190315687A1
Chemistry; metallurgy

Substituted Pyrrolidines and Methods of Use

#21 | 2019-05-09
US20190135827A1
Chemistry; metallurgy

Substituted Tricyclics and Method of Use

#22 | 2019-05-02
US20190127356A1
Chemistry; metallurgy

Substituted Chromanes and Method of Use

#23 | 2019-03-14
US20190077784A1
Chemistry; metallurgy

Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use

#24 | 2019-02-21
US20190055229A1
Chemistry; metallurgy

Heteroaryl substituted pyridines and methods of use

#25 | 2019-01-10
US20190008866A1
Human necessities

BROMODOMAIN INHIBITORS

#26 | 2018-11-22
US20180334435A1
Chemistry; metallurgy

6-HETEROARYLOXY- OR 6-ARYLOXY-QUINOLINE-2-CARBOXAMIDES AND METHOD OF USE

#27 | 2018-10-18
US20180298003A1
Chemistry; metallurgy

TETRACYCLIC BROMODOMAIN INHIBITORS

#28 | 2018-08-30
US20180244640A1
Chemistry; metallurgy

Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use

#29 | 2018-08-30
US20180244611A1
Chemistry; metallurgy

Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use

#30 | 2018-04-12
US20180099932A1
Chemistry; metallurgy

Substituted pyrrolidines and methods of use

#31 | 2018-04-12
US20180099931A1
Chemistry; metallurgy

Substituted pyrrolidines and methods of use

#32 | 2018-02-08
US20180037587A1
Chemistry; metallurgy

Substituted Tricyclics and Method of Use

#33 | 2017-12-07
US20170349576A1
Chemistry; metallurgy

Heteroaryl substituted pyridines and methods of use

#34 | 2017-10-26
US20170305891A1
Chemistry; metallurgy

Modulators of cystic fibrosis transmembrane conductance regulator protein

#35 | 2017-08-10
US20170226062A9
Chemistry; metallurgy

6-HETEROARYLOXY- OR 6-ARYLOXY-QUINOLINE-2-CARBOXAMIDES AND METHOD OF USE

#36 | 2017-07-06
US20170190693A1
Chemistry; metallurgy

SUBSTITUTED CHROMANES AND METHOD OF USE

#37 | 2017-01-19
US20170015675A1
Chemistry; metallurgy

Substituted tricyclics and method of use

#38 | 2016-12-08
US20160355482A1
Chemistry; metallurgy

6-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and method of use

#39 | 2016-11-17
US20160331749A1
Human necessities

Bromodomain inhibitors

#40 | 2016-05-05
US20160120841A1
Human necessities

Substituted chromanes and method of use

#41 | 2016-02-11
US20160039821A1
Chemistry; metallurgy

Substituted 1,4,10-triazadibenzo[cd,f]azulenes, substituted 1,4,5,10-tetraazadibenzo[cd,f]azulenes and substituted 1,4,5,7,10-pentaazadibenzo[cd,f]azulenes as bromodomain inhibitors

#42 | 2015-08-06
US20150218102A1
Chemistry; metallurgy

6-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and method of use

#43 | 2015-06-11
US20150158873A1
Chemistry; metallurgy

Bromodomain inhibitors

#44 | 2015-06-04
US20150150884A1
Human necessities

BROMODOMAIN INHIBITORS

#45 | 2014-09-11
US20140256710A1
Chemistry; metallurgy

Bromodomain inhibitors

#46 | 2014-03-13
US20140073700A1
Chemistry; metallurgy

GLYCYRRHETINIC ACID DERIVATIVES AND METHODS OF USE THEREOF

InventorID:

687208 โŽ˜